Company Filing History:
Years Active: 2019
Title: Ryota Taguchi: Innovator in Antibody Development
Introduction
Ryota Taguchi is a prominent inventor based in Kobe, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Ryota Taguchi holds a patent for an Anti-EphA4 antibody. This invention is designed to provide an anti-EphA4 antibody or an EphA4-binding fragment that can effectively bind to EphA4 and inhibit its interaction with its ligand. The patent also includes a pharmaceutical composition that comprises the anti-EphA4 antibody or the EphA4-binding fragment as an active ingredient. A mouse anti-EphA4 antibody with binding affinity for EphA4 was developed, and the sequences of the complementarity-determining regions (CDRs) of this antibody were identified. This advancement enabled the preparation of a humanized antibody that incorporates the CDR sequences from the mouse anti-EphA4 antibody in both the heavy chain and light chain variable regions.
Career Highlights
Ryota Taguchi is currently associated with Eisai R&D Management Co., Ltd., where he continues to innovate in the field of antibody research. His work is characterized by a commitment to advancing therapeutic solutions that can improve patient outcomes.
Collaborations
Throughout his career, Ryota has collaborated with notable colleagues, including Toshio Imai and Eiji Inoue. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Ryota Taguchi's contributions to the field of biotechnology, particularly through his patent on the Anti-EphA4 antibody, highlight his role as an innovator in antibody development. His work continues to pave the way for advancements in therapeutic applications.